
Introduction
Pharmaceutical companies face significant product waste when using flat-bottom vials for liquid doses. High Recovery Vials (HRVs) with conical bottoms reduce this waste by enabling maximum product retrieval without overfilling. WHEATON®, a provider of laboratory consumables, conducted a study comparing HRVs to flat-bottom vials.
Study Procedure
The study compared a standard 2mL flat-bottom vial, a WHEATON 2mL E-Z Ex-Traction® Vial, and a WHEATON 2mL NextGen™ V-Vial®. The procedure involved measuring the mass of dry, filled, and emptied vials to calculate filled volume, residual volume, percent waste, and percent decrease in waste.
Study Results
Flat-bottom vials had an average residual volume of 116.9µL, while E-Z Ex-Traction and NextGen V-Vials had 2.7µL and 1.1µL, respectively. The E-Z Ex-Traction Vial reduced waste by 97.7%, and the NextGen V-Vial by 99.1%.
Study Implications
For a 50L batch, flat-bottom vials resulted in 7.8% waste, while E-Z Ex-Traction and NextGen V-Vials reduced waste to 0.2% and 0.1%, respectively. This reduction allows for more fills per batch, offering long-term savings for manufacturers, especially for high-value products.
The WHEATON Solution
WHEATON offers two HRV options: the NextGen V-Vial and the E-Z Ex-Traction Vial. The NextGen V-Vial is suitable for high-value products, offering maximum protection and waste reduction. The E-Z Ex-Traction Vial is ideal for less expensive compounds, providing standard protection and reduced waste.
Conclusion
HRVs provide significant cost savings and efficiency improvements in pharmaceutical packaging by reducing product waste and eliminating the need for overfilling. They also prevent end users from pooling residual volumes to create additional dosages.
High Recovery Vials Reduce Residual Product Waste by 99% A Cost-Effective Alternative for Pharmaceutical Product Packaging White Paper
Open the catalog to page 1For primary packaging, particularly of high-value products including biologics and some vaccines, a high recovery vial such as the NextGen™ V-Vial® provides long-term savings for pharmaceutical manufacturers. INTRODUCTION Pharmaceutical companies manufacturing billions of liquid doses each year risk significant product waste when using flat-bottom vials for end user packaging. According to the U.S. Pharmacopoeia (USP), "each container of an injection contains sufficient excess" of the labeled dose or size to allow withdrawal of the labeled quantity of drug.1 High Recovery Vials (HRVs) that feature...
Open the catalog to page 2STUDY RESULTS The residual volume measured in each flat-bottom vial averaged 116.9|ul_. For the E-Z Ex-Traction, average residual volume was recorded as 2.7p_, while for the NextGen V-Vial, residual volume was 1.1|u_, as shown in Table 1; n = 25 for all trials. The E-Z Ex-Traction and NextGen V-Vials both significantly decrease product waste. The E-Z Ex-Traction Vial offers a 97.7% decrease in wasted residual product, while the NextGen V-Vial offers a reduction of 99.1%. In addition, HRVs eliminate the possibility of end users "pooling" residual volumes from individual vials to create additional...
Open the catalog to page 3SciLabware SciLabware Limited Unit 4, Riverside 2, Campbell Road, Stoke on Trent, ST4 4RJ, UK. Tel: +44 (0)1782 444406 Fax: +44 (0)1782 940436 J ^ Wheaton0 is a DWK Life Sciences Brand WHEATON® White Paper
Open the catalog to page 42 Pages
7 Pages
4 Pages
20 Pages
62 Pages
3 Pages
3 Pages
4 Pages
3 Pages
32 Pages
32 Pages
4 Pages
8 Pages
4 Pages
4 Pages
4 Pages
4 Pages
4 Pages
4 Pages
4 Pages
8 Pages
108 Pages
92 Pages